BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,646 | -84.0% | 114 | -74.4% | 0.00% | -100.0% |
| Q2 2022 | $29,000 | -17.1% | 446 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $35,000 | -7.9% | 446 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $38,000 | -25.5% | 446 | -30.1% | 0.00% | -33.3% |
| Q3 2021 | $51,000 | -21.5% | 638 | -20.4% | 0.00% | -25.0% |
| Q2 2021 | $65,000 | -4.4% | 802 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $68,000 | +6.2% | 802 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $64,000 | -57.6% | 802 | -57.4% | 0.01% | -66.7% |
| Q3 2020 | $151,000 | -20.9% | 1,882 | -15.4% | 0.02% | -28.6% |
| Q2 2020 | $191,000 | -28.5% | 2,224 | -32.2% | 0.02% | -34.4% |
| Q1 2020 | $267,000 | -48.6% | 3,282 | -47.1% | 0.03% | -31.9% |
| Q4 2019 | $519,000 | -74.2% | 6,209 | -73.0% | 0.05% | -74.5% |
| Q3 2019 | $2,011,000 | +7.8% | 22,990 | +0.9% | 0.18% | +10.8% |
| Q2 2019 | $1,866,000 | +5.0% | 22,789 | +4.3% | 0.17% | +5.1% |
| Q1 2019 | $1,777,000 | +22.0% | 21,853 | -1.3% | 0.16% | +5.3% |
| Q4 2018 | $1,457,000 | -28.0% | 22,130 | -15.7% | 0.15% | -27.2% |
| Q3 2018 | $2,024,000 | +25.3% | 26,259 | +20.0% | 0.21% | +16.4% |
| Q2 2018 | $1,615,000 | -3.5% | 21,875 | -15.0% | 0.18% | -11.5% |
| Q1 2018 | $1,673,000 | +7.0% | 25,722 | +6.4% | 0.20% | +4.7% |
| Q4 2017 | $1,563,000 | +18.4% | 24,175 | +14.9% | 0.19% | +9.8% |
| Q3 2017 | $1,320,000 | +19.7% | 21,038 | +15.5% | 0.17% | +9.4% |
| Q2 2017 | $1,103,000 | +413.0% | 18,213 | +339.9% | 0.16% | +488.9% |
| Q1 2017 | $215,000 | +220.9% | 4,140 | +176.4% | 0.03% | +200.0% |
| Q4 2016 | $67,000 | -9.5% | 1,498 | -3.2% | 0.01% | -10.0% |
| Q3 2016 | $74,000 | +5.7% | 1,548 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $70,000 | -38.6% | 1,548 | -44.1% | 0.01% | -56.5% |
| Q1 2016 | $114,000 | -80.8% | 2,771 | -82.2% | 0.02% | -81.5% |
| Q4 2015 | $595,000 | +44.4% | 15,607 | +24.6% | 0.12% | +37.8% |
| Q3 2015 | $412,000 | +17.0% | 12,527 | +149.4% | 0.09% | +23.3% |
| Q2 2015 | $352,000 | +4.5% | 5,023 | +2.4% | 0.07% | +1.4% |
| Q1 2015 | $337,000 | -76.9% | 4,905 | -75.3% | 0.07% | -78.7% |
| Q4 2014 | $1,456,000 | +2.3% | 19,858 | +0.1% | 0.34% | -8.9% |
| Q3 2014 | $1,423,000 | +1.3% | 19,832 | +2.0% | 0.37% | +0.3% |
| Q2 2014 | $1,405,000 | +5.6% | 19,438 | +7.5% | 0.37% | -4.9% |
| Q1 2014 | $1,330,000 | -1.5% | 18,083 | -6.8% | 0.39% | -0.5% |
| Q4 2013 | $1,350,000 | +5.5% | 19,408 | -0.4% | 0.39% | +0.8% |
| Q3 2013 | $1,280,000 | -7.7% | 19,493 | -2.7% | 0.39% | +0.5% |
| Q2 2013 | $1,387,000 | – | 20,026 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |